In particular, survival analysis revealed that infiltrative‐type HCC exhibited higher vascular invasion, microsatellite proportion and TP53 mutation, indicating a better response to adjuvant transarterial chemoembolization (TACE) than other HCC types. The gene discussed is TP53; the disease is hepatocellular carcinoma.